A Phase I Trial of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL0916)
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.24271
Full Text
Open PDFAbstract
Available in full text
Date
August 9, 2012
Authors
Publisher
Wiley